We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Mithra Pharmaceuticals SA (MITRA) NPV

Sell:€0.22 Buy:€0.23 Change: €0.009 (3.86%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:€0.22
Buy:€0.23
Change: €0.009 (3.86%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
Sell:€0.22
Buy:€0.23
Change: €0.009 (3.86%)
Market closed |  Prices as at close on 19 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Mithra Pharmaceuticals SA is a Belgian-based company active in the pharmaceutical industry. The Company is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The Company provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The Company also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The Company operates in more than 100 countries around the world and is headquartered in Liege, Belgium.

Contact details

Address:
Rue Saint-Georges 5
LIEGE
4000
Belgium
Telephone:
+32 (4) 3492822
Website:
https://www.mithra.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MITRA
ISIN:
BE0974283153
Market cap:
€15.59 million
Shares in issue:
69.11 million
Sector:
Pharmaceuticals
Exchange:
Euronext Brussels
Country:
Belgium
Currency:
Euro
Indices:
n/a

Key personnel

  • Christophe Marechal
    Co-Chief Executive Officer, Chief Financial Officer - Representative of CMM&C SPRL BVBA
  • Xavier Paoli
    Co-Chief Executive Officer, Chief Operating Officer
  • Laurence Schyns
    Chief Human Resource Officer
  • Graham Dixon
    Chief Scientific Officer, Representative of GD Lifescience SPRL
  • Jean-Michel Foidart
    President of the Scientific Council, Executive Director - Representative of Eva Consulting SRL
  • Benoit Mathieu
    Group Investor Relations Manager
  • Renaat Baes
    Chief Manufacturing Officer - Representative of MAREBA BVBA
  • Benjamin Brands
    Chief Supply Chain Officer - Representative of BGL Consulting SPRL
  • Cedric Darcis
    Chief Legal Officer
  • Jean-Manuel Fontaine
    Chief Commercial and External Affairs Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.